Repurposed drugs & anti-parasitics · Cancer · Published 2023-06-01 · By Henry Rearden
Cancer: Dr. Paul Marik's monograph on repurposed drugs (ivermectin, mebendazole) as adjuncts to cancer care
Source: Paul Marik MD, Independent Medical Alliance (formerly FLCCC), 'Cancer Care' / repurposed-drugs guide, updated 2026
Before you act: Don't stop, replace, or delay any cancer treatment without talking to your oncologist.
Evidence level
PHYSICIAN REPORT (narrative review / protocol, not peer-reviewed).
Funding
Published by a donor-funded nonprofit (IMA/FLCCC).
What was published
A physician-authored guide proposing repurposed drugs and nutraceuticals alongside conventional cancer treatment, ranking ivermectin and mebendazole among top agents.
What it shows
Marik reviews lab, animal and case evidence and proposes ivermectin, mebendazole and others as adjuncts.
What it does not show
It is a review and protocol, not a trial; no randomized trial has tested the combination.
Paper Trail Health summarizes published studies, case reports, court filings and journalism for general information. It is not medical, legal or investment advice. Summaries quote the sources; a source's statements are its authors', not findings of this site. Don't stop, replace, or delay treatment without your doctor. Always read the linked original. See Standards & corrections and Disclaimer.